It trades at a reasonable 20 times trailing earnings.
That fund is also filled with earnings growers (averaging 14% a year) at a reasonable price (average trailing price/earnings ratio is 26, not far from the ratio for the S&P 500).
Staples goes for 21 times trailing earnings, reasonable for a company on a successful expansion binge; Office Depot goes for 9 times.
This quality asset manager has a strong balance sheet and sells at a reasonable valuation: 20 times trailing earnings, 19 times forward earnings and at a 35% discount to its estimated $54 intrinsic value.
That looks very reasonable next to PepsiCo's trailing multiple of 21.
Still, the stock looks reasonable, trading at 13 times trailing earnings per share and just over one times sales.
The stock sells for 17 times trailing earnings and a reasonable 1.1 times sales.
For these reasons we believe that it would be reasonable and of interest to investigate whether also soluble TRAIL can be cleaved and/or inactivated by metalloproteases.
That puts the stock at approximately 26 times the trailing earnings, which is a reasonable multiple.
